FindTrial
Sign In

Post-Tranjugular intrahepatic Portosystemic Shunt (TIPS) Anticoagulation Therapy in Cirrhosis with Portal Vein Thrombosis

Post-Tranjugular intrahepatic Portosystemic Shunt (TIPS) Anticoagulation Therapy in Cirrhosis with Portal Vein Thrombosis

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002384
Enrollment
Unknown
Registered
2012-07-31
Start date
1990-01-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic cirrhosis, portal vein thrombosis

Interventions

AT-0:placebo
AT-12:recieve AT for 12m

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Liver cirrhosis; 2. Successful placement of TIPS; 3. Portal vein thrombosis; 4. Agreed to participate in the trial, and assigned informed consent.

Exclusion criteria

Exclusion criteria: 1. Younger than 18 years or older than 75 years; 2. Pregnant and breeding women; 3. Contraindication for anticoagulation; 4. complete occlusion of portal vein thrombosis 5. Malignancy or other serious medical illness which may reduce the life expectancy; 6. Uncontrolled infection or sepsis; 7. Severe disorders of other vital organs, such as heart, lung, kidney.

Design outcomes

Primary

MeasureTime frame
recanalization of thrombosis;rebleeding;survival;complication;—

Secondary

MeasureTime frame
hepatic encephalopathy;patency of shunt;—

Countries

China

Contacts

Public ContactXiao Li
simonlixiao@263.net+86 13881755965

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026